La vendita allo scoperto per Argan dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Argan. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Argan (NYSE:AGX) Azioni, Report sulle vendite allo scoperto

Argan

Argan, Inc.

AMEX

Argan Inc is a United States-base construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Telecom Services, out of which Power Services derive majority revenue.

Argan Inc

ANGLO ASIAN MNG PLC ORD by Anglo Asian Mining Plc.

Anglo Asian Mining PLC

Silver X Mining Corp

Agile Therapeutics Inc Warrants(13/10/2026)

Argentex Group PLC

Agilyx ASA

WIIM

IESC

MTRX

MYRG

ROAD

STRL

Shares of construction and engineering companies are trading higher after Donald Trump won the 2024 presidential election.

Argan's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) short percent of float has risen 50.65% since its last report. The company recently reported that it has 389 thousand shares sold short, which is 3.48% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.45 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Argan Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730919619_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Argan has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Argan's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Argan's peer group average for short interest as a percentage of float is 5.30%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Peering Into Argan's Recent Short Interest

A substantial insider sell was reported on September 23, by William F Leimkuhler, Director at Argan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>), based on the recent SEC filing.
What Happened: Leimkuhler's recent Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000100591/000136194324000004//Archives/edgar/data/100591/000136194324000004/0001361943-24-000004-index.htm">U.S. Securities and Exchange Commission</a> on Monday unveiled the sale of 10,000 shares of Argan. The total transaction value is $962,000.
Argan shares are trading down 0.0% at $96.25 at the time of this writing on Tuesday morning.
<h3>Unveiling the Story Behind Argan</h3>
Argan Inc is a United States-base construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Telecom Services, out of which Power Services derive majority revenue.
<h3>Unraveling the Financial Story of Argan</h3>
Revenue Growth: Argan's remarkable performance in 3 months is evident. As of 31 July, 2024, the company achieved an impressive revenue growth rate of 60.61%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Industrials sector.
Insights into Profitability:
<ul>
<li>
Gross Margin: The company issues a cost efficiency warning with a low gross margin of 13.7%, indicating potential difficulties in maintaining profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Argan's EPS is a standout, portraying a positive bottom-line trend that exceeds the industry average with a current EPS of 1.36.
</li>
</ul>
Debt Management: Argan's debt-to-equity ratio is below the industry average. With a ratio of 0.01, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Insights into Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: The Price to Earnings ratio of 30.17 is lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
Price to Sales (P/S) Ratio: A higher-than-average P/S ratio of 1.84 suggests overvaluation in the eyes of investors, considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): The company's EV/EBITDA ratio 17.38 is above the industry average, suggesting that the market values the company more highly for each unit of EBITDA. This could be attributed to factors such as strong growth prospects or superior operational efficiency.
</li>
</ul>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Uncovering the Importance of Insider Activity</h3>
In the complex landscape of investment decisions, investors should approach insider transactions as part of a comprehensive analysis, considering various elements.
In the context of legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as outlined by Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are obligated to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Despite insider sells not always signaling a bearish sentiment, they can be driven by various factors.
<h3>A Deep Dive into Insider Transaction Codes</h3>
When it comes to transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> tend to focus on those in the open market, detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S indicates a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000100591">Check Out The Full List Of Argan's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Insider Trades

Argan Director Sold $962K In Company Stock

Argan shares are trading higher following a quarterly cash dividend increase announcement by 25% from $0.30 per share to $0.375 per share.

The dividend will be payable on October 31, 2024, to stockholders of record at the close of business on October 23, 2024.

Dividends

Argan Boosts Quarterly Cash Dividend By 25% From $0.30 To $0.375 Per Share

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 400 points on Friday.
The Dow traded down 1.07% to 40,320.42 while the NASDAQ fell 2.61% to 16,680.93. The S&amp;P 500 also fell, dropping, 1.80% to 5,404.31.
Check This Out:<a href="https://www.benzinga.com/trading-ideas/long-ideas/24/09/40748893/over-40m-bet-on-pbf-energy-check-out-these-4-stocks-executives-are-buying"> Over $40M Bet On PBF Energy? Check Out These 4 Stocks Executives Are Buying</a>
Leading and Lagging Sectors Consumer staples shares slipped by just 0.1% on Thursday.
In trading on Thursday, communication services shares dipped by 2.8%.
Top Headline
The total number of active U.S. oil rigs came in unchanged at 483 rigs this week, Baker Hughes Inc reported.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>BloomZ Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) shares shot up 113% to $1.7250 after the company announced it entered into a business agreement with CrossVision for joint entertainment offerings.</li>
<li>Shares of Wheeler Real Estate Investment Trust, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WHLR#NASDAQ">WHLR</a>) got a boost, surging 119% to $9.08 after the company and its subsidiary, Cedar Realty Trust, announced that the United States Court of Appeals for the Fourth Circuit affirmed a 2023 order dismissing a putative class action complaint filed against the company and Cedar by purported holders of Cedar&#8217;s preferred stock.</li>
<li>Argan, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) shares were also up, gaining 25% to $89.22 after the company reported better-than-expected second-quarter financial results.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Braze, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) shares dropped 18% to $36.14 after the company reported quarterly financial results.</li>
<li>Shares of Planet Labs PBC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PL#NYSE">PL</a>) were down 27% to $1.8050 after the company reported worse-than-expected second-quarter sales results. Also, Needham maintained a Buy rating on the stock but lowered its price target from $7 to $5.</li>
<li>Genesco Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GCO#NYSE">GCO</a>) was down, falling 12% to $26.01 following second-quarter results.</li>
</ul>
Commodities In commodity news, oil traded down 2% to $67.74 while gold traded down 0.8% at $2,523.00.
Silver traded down 3% to $28.22 on Friday, while copper fell 1.7% to $4.0665.
Euro zone
European shares closed lower today. The eurozone's STOXX 600 dipped 1.07%, Germany's DAX fell 1.1483% and France's CAC 40 fell 1.07%. Spain's IBEX 35 Index fell 0.89%, while London's FTSE 100 fell 0.73%.
The GDP in the Eurozone grew by 0.2% on quarter during the second quarter. The number of employed persons in the Eurozone increased by 0.2% from the prior quarter during the three months to June.
Asia Pacific Markets
Asian markets closed lower on Friday, with Japan's Nikkei 225 falling 0.72%, China's Shanghai Composite Index falling 0.81% and India's BSE Sensex falling 1.24%.
Foreign exchange reserves held by the Reserve Bank of India jumped to $684 billion as of Aug. 30, 2024.
Economics
<ul>
<li>The U.S. economy added 142,000 jobs in August versus a revised 89,000 gain in July, but down from market estimates of 160,000.</li>
<li>The unemployment rate fell to 4.2% in August from 4.3% in the previous month.</li>
<li>Average hourly earnings for all employees rose by 0.4% to $35.21 in August compared to a 0.2% gain in July.</li>
<li>The total number of active U.S. oil rigs came in unchanged at 483 rigs this week, Baker Hughes Inc reported.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/09/40748612/jim-cramer-doesnt-like-carnival-right-now-royal-caribbean-is-the-one-you-want">Jim Cramer Doesn&#8217;t Like Carnival Right Now: Royal Caribbean Is &#8216;The One You Want&#8217;</a></li>
</ul>

Earnings

Equities

Eurozone

Commodities

Markets

BLMZ

BRZE

WHLR

Crude Oil Down 2%; Argan Shares Spike Higher

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 400 points on Friday.
The Dow traded down 0.97% to 40,360.43 while the NASDAQ fell 2.53% to 16,694.51. The S&amp;P 500 also fell, dropping, 1.69% to 5,410.46.
Check This Out:<a href="https://www.benzinga.com/trading-ideas/long-ideas/24/09/40748893/over-40m-bet-on-pbf-energy-check-out-these-4-stocks-executives-are-buying"> Over $40M Bet On PBF Energy? Check Out These 4 Stocks Executives Are Buying</a>
Leading and Lagging Sectors Consumer staples shares fell by just 0.3% on Thursday.
In trading on Thursday, information technology shares dipped by 2.6%.
Top Headline
The U.S. economy added 142,000 jobs in August versus a revised 89,000 gain in July, but down from market estimates of 160,000.
The unemployment rate fell to 4.2% in August from 4.3% in the previous month.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>BloomZ Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) shares shot up 159% to $2.0950 after the company announced it entered into a business agreement with CrossVision for joint entertainment offerings.</li>
<li>Shares of Wheeler Real Estate Investment Trust, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WHLR#NASDAQ">WHLR</a>) got a boost, surging 126% to $9.34 after the company and its subsidiary, Cedar Realty Trust, announced that the United States Court of Appeals for the Fourth Circuit affirmed a 2023 order dismissing a putative class action complaint filed against the company and Cedar by purported holders of Cedar&#8217;s preferred stock.</li>
<li>Argan, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) shares were also up, gaining 30% to $92.75 after the company reported better-than-expected second-quarter financial results.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Braze, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) shares dropped 17% to $36.70 after the company reported quarterly financial results.</li>
<li>Shares of Planet Labs PBC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PL#NYSE">PL</a>) were down 21% to $1.9707 after the company reported worse-than-expected second-quarter sales results. Also, Needham maintained a Buy rating on the stock but lowered its price target from $7 to $5.</li>
<li>Genesco Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GCO#NYSE">GCO</a>) was down, falling 14% to $25.33 following second-quarter results.</li>
</ul>
Commodities In commodity news, oil traded up 1.2% to $69.98 while gold traded down 0.3% at $2,536.70.
Silver traded down 0.2% to $29.04 on Friday, while copper fell 0.6% to $4.1130.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 rose 0.13%, Germany's DAX fell 0.13% and France's CAC 40 rose 0.22%. Spain's IBEX 35 Index rose 0.32%, while London's FTSE 100 rose 0.01%.
The GDP in the Eurozone grew by 0.2% on quarter during the second quarter. The number of employed persons in the Eurozone increased by 0.2% from the prior quarter during the three months to June.
Asia Pacific Markets
Asian markets closed lower on Friday, with Japan's Nikkei 225 falling 0.72%, China's Shanghai Composite Index falling 0.81% and India's BSE Sensex falling 1.24%.
Foreign exchange reserves held by the Reserve Bank of India jumped to $684 billion as of Aug. 30, 2024.
Economics
<ul>
<li>The U.S. economy added 142,000 jobs in August versus a revised 89,000 gain in July, but down from market estimates of 160,000.</li>
<li>The unemployment rate fell to 4.2% in August from 4.3% in the previous month.</li>
<li>Average hourly earnings for all employees rose by 0.4% to $35.21 in August compared to a 0.2% gain in July.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/09/40748612/jim-cramer-doesnt-like-carnival-right-now-royal-caribbean-is-the-one-you-want">Jim Cramer Doesn&#8217;t Like Carnival Right Now: Royal Caribbean Is &#8216;The One You Want&#8217;</a></li>
</ul>

Nasdaq Down Over 400 Points; Braze Shares Tumble After Q2 Results

U.S. stocks were mixed, with the Nasdaq Composite falling around 150 points on Friday.
Shares of Quanex Building Products Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NX#NYSE">NX</a>) rose sharply during Friday's session after the company reported better-than-expected third-quarter financial results and issued <a href="https://www.benzinga.com/quote/NX/earnings">FY24 guidance above estimates.</a>
Quanex Building Prods reported quarterly earnings of 73 cents per share which beat the analyst consensus estimate of 70 cents per share. The company reported quarterly sales of $280.300 million which beat the analyst consensus estimate of $278.457 million.
Quanex Building Products shares jumped 19.9% to $29.80 on Friday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Argan, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) gained 28.4% to $91.64 after the company reported better-than-expected second-quarter financial results.</li>
<li>Travere Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVTX#NASDAQ">TVTX</a>) shares rose 15.3% to $11.45 after the company announced it that the FDA has granted full approval to FILSPARI to slow kidney function decline in adults with primary IgAN who are at risk of disease progression. Also, HC Wainwright &amp; Co maintained a Buy rating on the stock and raised its price target from $20 to $23.</li>
<li>Zumiez Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZUMZ#NASDAQ">ZUMZ</a>) rose 15.3% to $29.67 following quarterly results.</li>
<li>Samsara Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IOT#NYSE">IOT</a>) gained 15% to $44.58 after the company reported better-than-expected quarterly financial results and raised its FY25 guidance.</li>
<li>Pacific Biosciences of California, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PACB#NASDAQ">PACB</a>) gained 14.6% to $1.6050.</li>
<li>Guidewire Software, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>) rose 13.9% to $163.94 after the company reported better-than-expected quarterly financial results. Also, Oppenheimer and Baird maintained an Outperform rating on the stock and raised their respective price targets.</li>
<li>Bowlero Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOWL#NYSE">BOWL</a>) climbed 13.5% to $12.25 after the company reported better-than-expected fourth-quarter sales results and issued FY25 revenue guidance above estimates.</li>
<li>Polestar Automotive Holding UK PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNY#NASDAQ">PSNY</a>) gained 9.7% to $1.4485.</li>
<li>Smartsheet Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMAR#NYSE">SMAR</a>) rose 9.6% to $54.11 following better-than-expected quarterly financial results. The company also raised its FY25 EPS outlook.</li>
<li>Brady Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRC#NYSE">BRC</a>) gained 6.8% to $76.75 after the company reported better-than-expected quarterly adjusted EPS results. Also, the company authorized an additional $100 million of shares for repurchase.</li>
<li>NIO Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) rose 6% to $5.14 after JP Morgan upgraded the stock from Neutral to Overweight and raised its price target from $5.30 to $8.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40748814/top-4-financials-stocks-that-may-crash-this-month">Top 4 Financials Stocks That May Crash This Month</a></li>
</ul>

Intraday Update

Movers

BOWL

GWRE

PACB

PSNY

SMAR

TVTX

ZUMZ

Quanex Building Products Posts Better-Than-Expected Results, Joins Zumiez, Guidewire Software, Smartsheet And Other Big Stocks Moving Higher On Friday

Argan shares are trading higher after the company reported better-than-expected Q2 financial results.

Shares of Argan, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) rose sharply in today's pre-market trading after the company reported better-than-expected <a href="https://www.benzinga.com/quote/AGX/earnings">second-quarter financial results.</a>
Argan reported quarterly earnings of $1.31 per share which beat the analyst consensus estimate of 92 cents per share. The company reported quarterly sales of $227.015 million which beat the analyst consensus estimate of $183.550 million.
Argan shares jumped 18.4% to $84.54 in the pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Wheeler Real Estate Investment Trust, Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WHLR#NASDAQ">WHLR</a>) gained 175.8% to $11.42 in pre-market trading after jumping 302% on Thursday.</li>
<li>BloomZ Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) rose 52.3% to $1.23 in today's pre-market trading after the company announced it entered into a business agreement with CrossVision for joint entertainment offerings.</li>
<li>Vor Biopharma Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOR#NASDAQ">VOR</a>) gained 27.3% to $1.05 in the pre-market trading session. Vor Bio releaseD new clinical data confirming the effectiveness of shielded transplants for delivering targeted therapies.</li>
<li>Faraday Future Intelligent Electric Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) gained 24.8% to $6.52 in pre-market trading after the company announced $30 million in financing commitments from the Middle East, the United States, and Asia.</li>
<li>BurgerFi International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFI#NASDAQ">BFI</a>) gained 17.3% to $0.2135 in pre-market trading after jumping over 26% on Thursday.</li>
<li>Bowlero Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOWL#NYSE">BOWL</a>) shares gained 14.9% to $12.40 in pre-market trading after the company posted strong quarterly sales.</li>
<li>Meiwu Technology Co Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WNW#NASDAQ">WNW</a>) gained 13.6% to $0.92 in pre-market trading.</li>
<li>Quanex Building Products Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NX#NYSE">NX</a>) gained 8.6% to $27.00 in pre-market trading r after the company reported better-than-expected third-quarter financial results and issued FY24 guidance above estimates.</li>
<li>Guidewire Software, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>) rose 6.4% to $153.11 in pre-market trading after the company reported better-than-expected fourth-quarter financial results.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Inspire Veterinary Partners, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVP#NASDAQ">IVP</a>) fell 20.1% to $0.9349 in pre-market trading after jumping 63% on Thursday. Inspire Veterinary Partners recently signed a non-binding letter of intent (LOI) to acquire AI platform Vetaie.ai in an all-stock transaction.</li>
<li>Hoth Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOTH#NASDAQ">HOTH</a>) shares fell 19.8% to $1.01 in pre-market trading. Hoth Therapeutics shares surged 81% on Thursday after the company announced data from the treatment of epidermal growth factor receptor inhibitor associated papulopustular eruptions with its novel therapeutic HT-001.</li>
<li>Eastside Distilling, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EAST#NASDAQ">EAST</a>) shares fell 17.4% to $1.19 in pre-market trading after jumping 89% on Thursday. Eastside Distilling announced a $0.4 million registered direct offering, priced at a premium to market under Nasdaq rules.</li>
<li>Clene Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNN#NASDAQ">CLNN</a>) shares declined 17.4% to $5.21 in pre-market trading after falling 5% on Thursday.</li>
<li>ThredUp Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TDUP#NASDAQ">TDUP</a>) shares declined 16.1% to $0.73 in pre-market trading.</li>
<li>Autozi Internet Technology (Global) Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZI#NASDAQ">AZI</a>) fell 12.2% to $1.59 in pre-market trading after dipping 35% on Thursday.</li>
<li>Sify Technologies Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIFY#NASDAQ">SIFY</a>) fell 10.5% to $0.4743 in today's pre-market trading after dipping 18% on Thursday.</li>
<li>Planet Labs PBC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PL#NYSE">PL</a>) shares fell 9.7% to $2.24 in pre-market trading after the company posted downbeat quarterly sales.</li>
<li>Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) shares dipped 9.4% to $138.51 in pre-market trading. Broadcom reported better-than-expected third-quarter financial results after the closing bell on Thursday. The company said it expects fourth-quarter revenue of approximately $14 billion.</li>
<li>Smith &amp; Wesson Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWBI#NASDAQ">SWBI</a>) declined 8.7% to $12.96 in pre-market trading after the company reported worse-than-expected first-quarter financial results on Thursday.</li>
</ul>
Now Read This:
<ul>
<li><a href="https://www.benzinga.com/top-stories/24/09/40730015/jim-cramer-oklo-is-losing-money-hand-over-fist-but-this-private-equity-stock-is-a-buy"> Jim Cramer: Oklo Is Losing Money &#8216;Hand-Over-Fist,&#8217; But This Private Equity Stock Is A Buy</a></li>
</ul>

Pre-Market Outlook

AVGO

CLNN

EAST

FFIE

HOTH

SIFY

SWBI

TDUP

Why Argan Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Argan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) reported quarterly earnings of $1.31 per share which beat the analyst consensus estimate of $0.92 by 42.39 percent. The company reported quarterly sales of $227.015 million which beat the analyst consensus estimate of $183.550 million by 23.68 percent. This is a 60.61 percent increase over sales of $141.349 million the same period last year.

Earnings Beats

Argan Q2 2024 GAAP EPS $1.31 Beats $0.92 Estimate, Sales $227.015M Beat $183.550M Estimate

PRIM

USLM

Shares of building and construction-related stocks are trading lower after July construction spending data missed estimates. The sector may be moving lower amid overall market weakness after August's ISM Manufacturing PMI data indicated an economic contraction.

Management

Argan Appoints Josh Baugher As CFO; Succeeds Richard Deily Effective Sept. 15

Lake Street analyst Robert Brown maintains Argan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) with a Buy and raises the price target from $70 to $85.

Price Target

Analyst Ratings

Lake Street Maintains Buy on Argan, Raises Price Target to $85

Shares of GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) fell sharply during Friday's session after the company released worse-than-expected first-quarter results before schedule and filed to <a href="https://www.benzinga.com/news/earnings/24/06/39224137/gamestop-releases-q1-results-ahead-of-roaring-kitty-event-files-prospectus-to-raise-capital-via-equ">sell up to 75 million shares</a>.
GameStop released its first-quarter 2024 results early Friday ahead of its scheduled June 11 date. The company reported net sales of $881.8 million, down from $1.237 billion year-over-year. The net sales total missed a consensus estimate of $995.3 million. The company reported a loss of 12 cents per share, missing the estimate of a loss of 9 cents per share, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
GameStop shares dipped 22.5% to $36.07 on Friday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Trinity Place Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPHS#NYSE">TPHS</a>) jumped 165.4% to $0.3220 after declining around 11% on Thursday.</li>
<li>Leafly Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFLY#NASDAQ">LFLY</a>) shares gained 91.6% to $3.87.</li>
<li>Venus Concept Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) shares jumped 87.5% to $1.1606 on continued upward momentum after the stock regained Nasdaq compliance.</li>
<li>Asensus Surgical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASXC#NASDAQ">ASXC</a>) climbed 40.1% to $0.3291 after the company announced it will be acquired by KARL STORZ for $0.35 per share in cash.</li>
<li>Faraday Future Intelligent Electric Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) gained 29.3% to $0.7032.</li>
<li>Geron Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GERN#NASDAQ">GERN</a>) shares jumped 26% to $4.90 as the company reported the FDA approval of RYTELO&#x2122; (imetelstat), a first-in-class telomerase inhibitor, for the treatment of adult patients with lower-risk MDS with transfusion-dependent anemia.</li>
<li>China Liberal Education Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLEU#NASDAQ">CLEU</a>) gained 23.4% to $2.4899.</li>
<li>American Oncology Network, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AONC#NASDAQ">AONC</a>) gained 22.6% to $2.0850. American Oncology Network recently announced the opening of Low Country Radiation in Waycross, Georgia.</li>
<li>MAIA Biotechnology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAIA#NASDAQ">MAIA</a>) rose 21.2% to $4.0249. The company unveiled compelling efficacy data from its Phase 2 THIO-101 clinical trial.</li>
<li>ChromaDex Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDXC#NASDAQ">CDXC</a>) gained 19.2% to $3.41 after the company received exclusive FDA Orphan Drug Designation and Rare Pediatric Disease Designation for Nicotinamide Riboside Chloride in the treatment of Ataxia Telangiectasia.</li>
<li>SunPower Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPWR#NASDAQ">SPWR</a>) rose 18.8% to $4.11.</li>
<li>Oddity Tech Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODD#NASDAQ">ODD</a>) gained 18.3% to $43.49 after the company approved a share buyback and raised its Q2 guidance.</li>
<li>Universe Pharmaceuticals INC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) jumped 14.3% to $2.64</li>
<li>Presto Automation Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRST#NASDAQ">PRST</a>) rose 14.1% to $0.0866 after declining 27% on Thursday.</li>
<li>Yext, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YEXT#NYSE">YEXT</a>) gained 14.7% to $5.42. Yext is said to hire investment bankers to explore strategic alternatives, including a sale, Reuters reported.</li>
<li>Argan, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) jumped 11.1% to $76.78 after the company reported better-than-expected first-quarter financial results.</li>
<li>Planet Labs PBC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PL#NYSE">PL</a>) gained 9.6% to $1.9950 following better-than-expected quarterly earnings.</li>
<li>Braze, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) rose 4.2% to $38.32 following better-than-expected first-quarter earnings.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Biomea Fusion, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMEA#NASDAQ">BMEA</a>) shares dipped 65.6% to $3.87 after the United States Food and Drug Administration (FDA) imposed a full clinical hold on its Phase I/II trials for BMF-219, a diabetes treatment.</li>
<li>Barnes &amp; Noble Education, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BNED#NYSE">BNED</a>) fell 35.3% to $0.2101 after the company announced final results of rights offering.</li>
<li>Scinai Immunotherapeutics Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCNI#NASDAQ">SCNI</a>) fell 31.3% to $2.7474. Scinai Immunotherapeutics regained compliance with Nasdaq minimum bid price requirement.</li>
<li>Volcon, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VLCN#NASDAQ">VLCN</a>) fell 29.3% to $9.90. Volcon recently announced a 1-for-100 reverse stock split.</li>
<li>Latam Logistic Properties, S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LPA#NYSE">LPA</a>) shares fell 26.4% to $34.69 after jumping 49% on Thursday.</li>
<li>Hywin Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HYW#NYSE">HYW</a>) dipped 24.7% to $0.4670.</li>
<li>MicroAlgo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLGO#NASDAQ">MLGO</a>) shares fell 24.2% to $4.24. MicroAlgo recently announced that it entered into convertible note purchase agreements with certain investors.</li>
<li>Actelis Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASNS#NASDAQ">ASNS</a>) dipped 23% to $1.5101. Actelis announced closing of exercise of warrants for $3 million gross proceeds.</li>
<li>Semtech Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) dipped 19.6% to $30.54 after the company announced it has appointed a new President and CEO and reaffirmed Q2 2025 guidance.</li>
<li>Gorilla Technology Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRRR#NASDAQ">GRRR</a>) fell 19.3% to $4.7699 after announcing a $12 million registered direct offering.</li>
<li>Bright Green Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGXX#NASDAQ">BGXX</a>) shares fell 18.7% to $0.2851 after declining around 8% on Thursday.</li>
<li>Seres Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCRB#NASDAQ">MCRB</a>) declined 18.7% to $0.6916. Canaccord Genuity analyst John Newman maintained Seres Therapeutics with a Buy and lowered the price target from $15 to $10.</li>
<li>CEA Industries Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEAD#NASDAQ">CEAD</a>) dipped 18% to $6.65.</li>
<li>Oil-Dri Corporation of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ODC#NYSE">ODC</a>) fell 17.3% to $68.57 following third-quarter results.</li>
<li>mF International Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MFI#NASDAQ">MFI</a>) fell 17.1% to $1.07.</li>
<li>Vail Resorts, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTN#NYSE">MTN</a>) shares declined 13.6% to $167.50 after the company reported weaker-than-expected results for its third quarter on Thursday.</li>
<li>Samsara Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IOT#NYSE">IOT</a>) shares dipped 13.4% to $30.17 after the company reported first-quarter earnings.</li>
<li>Moving iMage Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MITQ#NYSE">MITQ</a>) fell 10.3% to $0.6001 after declining 33% on Thursday. Moving iMage Technologies was recently awarded a multi-million dollar contract.</li>
<li>Novavax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) declined 10.2% to $17.56.</li>
<li>Sify Technologies Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIFY#NASDAQ">SIFY</a>) fell 10.1% to $0.8001 as the company announced commencement of its previously announced rights offering.</li>
<li>Harmony Gold Mining Company Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMY#NYSE">HMY</a>) fell 9.2% to $8.36. Shares of precious metals companies traded lower amid a decline in gold and silver following US economic data.</li>
<li>Concrete Pumping Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBCP#NASDAQ">BBCP</a>) shares dipped 8% to $6.93 after posting weaker-than-expected second-quarter results.</li>
<li>Upstart Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>) tumbled 8% to $24.75.</li>
<li>American Software, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSWA#NASDAQ">AMSWA</a>) declined 7.5% to $9.55 following quarterly results. B. Riley Securities analyst Zach Cummings maintained American Software with a Buy and lowered the price target from $16 to $14.</li>
<li>DocuSign, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) shares fell 7.4% to $50.57. DocuSign reported better-than-expected earnings for its first quarter and the company&#8217;s board also authorized a $1 billion increase to its existing stock repurchase program. The company said it sees second-quarter billings in the range of $715 million to $725 million.</li>
<li>Impinj, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PI#NASDAQ">PI</a>) fell 7.1% to $153.03.</li>
<li>Gen Digital Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEN#NASDAQ">GEN</a>) declined 5.2% to $24.13 after Morgan Stanley downgraded the stock from Overweight to Equal-Weight and lowered its price target from $28 to $27.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/06/39226995/over-2m-bet-on-this-tech-stock-check-out-these-4-stocks-insiders-are-buying">Over $2M Bet On This Tech Stock? Check Out These 4 Stocks Insiders Are Buying</a>

AMSWA

AONC

ASNS

ASXC

BBCP

BGXX

BMEA

BNED

CDXC

CEA INDUSTRIES INC by CEA Industries Inc.

CEAD

CLEU

DOCU

GERN

GRRR

LFLY

MAIA

MCRB

MITQ

MLGO

NVAX

PRST

SCNI

SMTC

SPWR

TPHS

UPST

VERO

VLCN

YEXT

Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>Virco Mfg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRC#NASDAQ">VIRC</a>) shares increased by 17.9% to $12.81 during Friday's regular session. The company's market cap stands at $209.4 million. As per the news, the Q1 earnings report came out today. </li>
<li>Montana Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRJ#NASDAQ">AIRJ</a>) stock increased by 13.78% to $11.64. The market value of their outstanding shares is at $626.5 million. </li>
<li>SunPower (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPWR#NASDAQ">SPWR</a>) shares rose 12.71% to $3.9. The company's market cap stands at $684.3 million. </li>
<li>ZKH Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZKH#NYSE">ZKH</a>) shares moved upwards by 11.31% to $12.0. The market value of their outstanding shares is at $1.9 billion. </li>
<li>Clean Energy Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETY#NASDAQ">CETY</a>) shares rose 10.61% to $1.25. The company's market cap stands at $53.6 million. </li>
<li>Argan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) stock rose 10.18% to $76.19. The company's market cap stands at $1.0 billion. The company's, Q1 earnings came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Expion360 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XPON#NASDAQ">XPON</a>) stock declined by 17.9% to $1.24 during Friday's regular session. The market value of their outstanding shares is at $9.2 million. </li>
<li>Zoomcar Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCAR#NASDAQ">ZCAR</a>) stock decreased by 17.25% to $0.16. The company's market cap stands at $10.6 million. </li>
<li>Concrete Pumping Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBCP#NASDAQ">BBCP</a>) stock fell 13.42% to $6.52. The company's market cap stands at $351.2 million. As per the press release, Q2 earnings came out yesterday. </li>
<li>1847 Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EFSH#AMEX">EFSH</a>) shares decreased by 13.41% to $0.71. The market value of their outstanding shares is at $4.1 million. </li>
<li>Jayud Global Logistics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JYD#NASDAQ">JYD</a>) stock declined by 13.23% to $0.55. The company's market cap stands at $11.7 million. </li>
<li>Shengfeng Development (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFWL#NASDAQ">SFWL</a>) shares fell 12.28% to $0.96. The company's market cap stands at $79.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIRJ

CETY

EFSH

SFWL

VIRC

XPON

ZCAR

12 Industrials Stocks Moving In Friday's Intraday Session

U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Friday.
Shares of Argan, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) rose sharply during Friday's session after the company reported better-than-expected <a href="https://www.benzinga.com/quote/AGX/earnings">first-quarter financial results</a>.
Argan posted quarterly earnings of 58 cents per share, beating market estimates of 52 cents per share. The company's quarterly sales came in at $157.68 million versus expectations of $134.75 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Argan shares climbed 11.1% to $76.78 on Thursday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul>
<li>Geron Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GERN#NASDAQ">GERN</a>) shares climbed 26% to $4.90 as the company reported the FDA approval of RYTELO&#x2122; (imetelstat), a first-in-class telomerase inhibitor, for the treatment of adult patients with lower-risk MDS with transfusion-dependent anemia.</li>
<li>SunPower Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPWR#NASDAQ">SPWR</a>) shares jumped 18.8% to $4.11.</li>
<li>Oddity Tech Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODD#NASDAQ">ODD</a>) rose 18.3% to $43.49 after the company approved a share buyback and raised its Q2 guidance.</li>
<li>Yext, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YEXT#NYSE">YEXT</a>) climbed 14.7% to $5.42. Yext is said to hire investment bankers to explore strategic alternatives, including a sale, Reuters reported.</li>
<li>Planet Labs PBC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PL#NYSE">PL</a>) climbed 9.6% to $1.9950 following better-than-expected quarterly earnings.</li>
<li>Limoneira Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) gained 9.4% to $22.27 as the company reported financial results for the second quarter ended April 30, 2024.</li>
<li>Esperion Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESPR#NASDAQ">ESPR</a>) gained 8.7% to $2.6850.</li>
<li>Waldencast plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WALD#NASDAQ">WALD</a>) rose 8.6% to $4.77.</li>
<li>NWTN Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWTN#NASDAQ">NWTN</a>) climbed 8.5% to $2.17.</li>
<li>Dave Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) gained 7.8% to $39.57. B. Riley Securities analyst Hal Goetsch initiated coverage on Dave with a Buy rating and announced a price target of $60.</li>
<li>Mobileye Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>) rose 7.6% to $29.48.</li>
<li>Credo Technology Group Holding Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NASDAQ">CRDO</a>) gained 7.2% to $27.72.</li>
<li>Braze, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) gained 4.2% to $38.32 following better-than-expected first-quarter earnings.</li>
<li>Carvana Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) rose 3.7% to $108.49.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/06/39227364/this-exxon-mobil-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-friday">This Exxon Mobil Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday</a>

CRDO

CVNA

DAVE

ESPR

LMNR

MBLY

NWTN

WALD

Argan Reports Strong Earnings, Joins Geron, Planet Labs PBC And Other Big Stocks Moving Higher On Friday

Argan shares are trading higher after the company reported better-than-expected Q1 financial results.

Argan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) reported quarterly earnings of $0.58 per share which beat the analyst consensus estimate of $0.52 by 11.54 percent. This is a 262.5 percent increase over earnings of $0.16 per share from the same period last year. The company reported quarterly sales of $157.68 million which beat the analyst consensus estimate of $134.75 million by 17.02 percent. This is a 52.09 percent increase over sales of $103.67 million the same period last year.

Argan Q1 EPS $0.58 Beats $0.52 Estimate, Sales $157.68M Beat $134.75M Estimate

Argan ( ($AGX) ) has provided an announcement. Argan, Inc. has announced significant leadership changes and salary adjustments, with Joshua S. Baug...

Argan Announces Executive Changes and Dividend Increase

Dividend Roundup: Microsoft, JPMorgan, CVS Health, Nucor, and more.

Rate Cut Winners: Top 5 Small-Caps Ready For A Rally

In this video, I review the overall market and its leading industry groups. I also provide two new EOD swing setups in two slightly extended names.

Strong Jobs Report Ignites Bond Yields; Two New Swing Positions

Argan: Favorable Long Term Due To Robust Project Pipeline

Construction conglomerate Argan ($AGX) has seen robust top-line growth of over 60% in the most recent quarter, driven by strong demand and heighten...

Argan (AGX) Delivers Promising Returns Fueled by Surging Energy Demand

Financials and Industrials passed 30% 52-week highs simultaneously

Trump Vs. Harris: 7 Election Stocks To Position Your Portfolio For Q4

Top stock picks to consider if Trump or Harris wins the White House – SA's Steven Cress

Argan (AGX) is down -9.8%, or -$14.62 to $134.61. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial n...

Argan falls -9.8%

ACVF

AFRM

AMSC

DELL

DEMZ

FCNCA

FMCC

FSLR

GRBK

HYLN

KRUZ

LOGI

LWAY

MAGA

MSFT

MSTR

NANC

NECB

OPFI

POWL

PSIX

RAIL

RYAN

SKYW

TRUP

YALL

ZETA

Press Releases

Argan, Inc. to Announce First Quarter Fiscal 2025 Results and Host Conference Call on Thursday, June 6, 2024

Argan, Inc. Reports First Quarter Fiscal 2025 Results

Argan, Inc. Declares Regular Quarterly Cash Dividend of $0.30 Per Common Share

Argan, Inc. Announces Chief Financial Officer Retirement and Succession

Argan, Inc. to Announce Second Quarter Fiscal 2025 Results and Host Conference Call on Thursday, September 5, 2024

Argan, Inc. to Attend the Lake Street Capital Markets 8th Annual Best Ideas Growth Conference

Argan, Inc. Reports Second Quarter Fiscal 2025 Results

Argan, Inc. Increases Quarterly Dividend by 25% to $0.375 Per Common Share

Argan, Inc. Announces the Passing of Board Member W.G. Champion Mitchell

Argan, Inc. to Announce Third Quarter Fiscal 2025 Results and Host Conference Call on Thursday, December 5, 2024

CRAI

Arcosa

AECOM

Ameresco

APi Gr

Bowman Consulting Group Ltd. - Common Stock

Bowman Consulting Group

Cadeler A/S American Depositary Share (each representing four (4) Ordinary Shares)

Comments

Argan

Vendite allo scoperto

Argan (NYSE:AGX) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO